Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine–associated myocarditis
Anis Barmada, Jon Klein, Anjali Ramaswamy, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 48

Showing 26-50 of 48 citing articles:

Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines
George Kassianos, Pauline MacDonald, Ivan Dinesh Aloysius, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 57-57
Open Access | Times Cited: 1
New insights gained from cellular landscape changes in myocarditis and inflammatory cardiomyopathy
Weiteng Wang, Hao Jia, Xiumeng Hua, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 5, pp. 883-907
Closed Access | Times Cited: 1
Beyond the injection site: identifying the cellular targets of mRNA vaccines
Tudor Emanuel Fertig, Victor Eduard Peteu, Daciana Marta, et al.
Journal of Cell Identity (2024) Vol. 3, Iss. 1
Closed Access | Times Cited: 1
PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cells
Stephen M. Lanahan, Lucas Yang, Kate M. Jones, et al.
Nature Immunology (2024) Vol. 25, Iss. 8, pp. 1422-1431
Closed Access | Times Cited: 1
COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy
Heidi N. du Preez, Johnson Lin, Glenn E. M. Maguire, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Open Access | Times Cited: 1
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions
Kuei-Ching Hsiung, Huan-Jung Chiang, Sebastian Reinig, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1345-1345
Open Access | Times Cited: 1
COVID-19 Vaccines and Myocardial Injury
David A. Bluemke
Radiology (2023) Vol. 308, Iss. 3
Closed Access | Times Cited: 4
Clinical course and follow-up of pediatric patients with COVID-19 vaccine-associated myocarditis compared to non–vaccine-associated myocarditis within the prospective multicenter registry—“MYKKE”
Nele Rolfs, Cynthia Huber, E. Schwarzkopf, et al.
American Heart Journal (2023) Vol. 267, pp. 101-115
Open Access | Times Cited: 4
Mental stress, atheroma, myocardial ischaemia and injury: the link is inflammation
H T Ong, Jinghong Chen
General Psychiatry (2023) Vol. 36, Iss. 6, pp. e101282-e101282
Open Access | Times Cited: 3
HLA binding‐groove motifs are associated with myocarditis induction after Pfizer‐BioNTech BNT162b2 vaccination
Aviran Aharon, Gil Benedek, Barhoum Barhoum, et al.
European Journal of Clinical Investigation (2023) Vol. 54, Iss. 4
Open Access | Times Cited: 2
Case of Myocarditis, Pericarditis, and Fatal Aortic Dissection following Covid-19 mRNA Vaccination
Eduardo J Balbona, Heather Hudson, Janci Lindsay, et al.
(2024)
Open Access
« ReNAissance » des biothérapies par ARN
Bruno Pitard, Irène Pitard
médecine/sciences (2024) Vol. 40, Iss. 6-7, pp. 525-533
Open Access
Pandemic, science and health: between determinisms and determinations
Marcelo Simões Mendes
Journal of Public Health (2024)
Closed Access
Novel insights into the heterogeneity of FOXP3 + Treg cells in drug-induced allergic reactions through single-cell transcriptomics
Wei Shen, Yibo Liang, Dong Lv, et al.
Immunologic Research (2024) Vol. 72, Iss. 5, pp. 1071-1085
Closed Access
Sex, Gender, and Other Factors That Influence Infections for Men and Women
Chandler Johnson, Amy Baldwin, Lia Pierson Bruner, et al.
Infectious Diseases in Clinical Practice (2024) Vol. 32, Iss. 5, pp. 1405-1405
Closed Access
The BNT162b2 mRNA vaccine demonstrates reduced age-associated TH1 support in vitro and in vivo
Byron Brook, Abhinav Kumar Checkervarty, Soumik Barman, et al.
iScience (2024) Vol. 27, Iss. 11, pp. 111055-111055
Open Access
An anti-Shiga toxin VHH nanobody multimer protects mice against fatal toxicosis when administered intramuscularly as repRNA
Sally R. Robinson, Denise Dayao, Jhon A. Medina, et al.
Infection and Immunity (2024) Vol. 92, Iss. 11
Open Access
Timing of rejection events preceded by Covid-19 mRNA vaccination in recipients of solid organ transplants
Quentin Perrier, Johan Noble, Agnès Bonadona, et al.
Vaccine (2024) Vol. 45, pp. 126617-126617
Open Access
The discovery and development of mRNA vaccines for the prevention of SARS-CoV-2 infection
Vivian Weiwen Xue, Sze Chuen Cesar Wong, Bo Li, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 7, pp. 769-780
Closed Access | Times Cited: 1
Uneventful COVID-19 Infection and Vaccination in a Cohort of Patients with Prior Myocarditis
Anna Baritussio, Andrea Silvio Giordani, Cristina Basso, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1742-1742
Open Access | Times Cited: 1
Response by Yonker et al to Letter Regarding Article, “Circulating Spike Protein Detected in Post–COVID-19 mRNA Vaccine Myocarditis”
Lael M. Yonker, Alessio Fasano, David R. Walt
Circulation (2023) Vol. 148, Iss. 11, pp. 910-911
Closed Access
Autoinflammatorische Prozesse besser verstehen
Christian Huemer
rheuma plus (2023) Vol. 22, Iss. 5, pp. 231-233
Closed Access
Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein driving the genesis of Omicron variants
Qihong Yan, Xijie Gao, Banghui Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Previous Page - Page 2

Scroll to top